HQ Function

The headquarters served as the primary center for research and development, program management, and administrative operations for Casebia's gene editing initiatives, focusing on translating CRISPR/Cas9 technology into viable therapeutics.

Notable Features:

Located in a modern biotech facility within Kendall Square, offering state-of-the-art laboratory spaces, advanced research equipment, and collaborative work environments designed to foster innovation.

Work Culture:

As a cutting-edge research-focused biotech venture, the work culture at Casebia Therapeutics emphasized scientific excellence, innovation, rigorous collaboration, and a strong mission-driven approach to developing transformative treatments for severe genetic diseases.

HQ Significance:

The Cambridge headquarters was strategically significant due to its location in Kendall Square, providing access to world-class academic institutions (like MIT and Harvard), a rich talent pool, and a dense ecosystem of biotech companies, VCs, and research organizations, fostering collaboration and accelerating R&D.

Values Reflected in HQ: The headquarters' design and operational focus would have reflected values such as scientific pioneering, cutting-edge innovation, a commitment to quality and safety in research, and a dedicated pursuit of developing therapies for patients with unmet medical needs.

Location:

During its operation as a joint venture, Casebia Therapeutics leveraged the global research, development, and clinical expertise of its parent companies, CRISPR Therapeutics (with operations in the US and Europe) and Bayer (a global pharmaceutical company). Casebia's direct operational footprint was primarily in the United States, with its headquarters and main research facility in Cambridge, MA, and a planned research presence in San Francisco, CA. Following its integration, its programs and intellectual property became part of CRISPR Therapeutics' global R&D pipeline and strategy.

Street Address:

100 Binney Street, Suite 600 (Primary operational address; also closely associated with CRISPR Therapeutics' facilities such as 610 Main Street)

City:

Cambridge

State/Province:

Massachusetts

Country:

USA